AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 101 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,085,396 | -43.5% | 640,344 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $7,225,134 | -21.7% | 651,500 | +8.3% | 0.00% | -50.0% |
| Q1 2023 | $9,231,597 | -21.2% | 601,407 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $11,713,102 | +49.1% | 527,855 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $7,854,000 | +18.3% | 480,908 | +5.3% | 0.00% | +100.0% |
| Q2 2022 | $6,639,000 | -3.7% | 456,914 | +22.4% | 0.00% | 0.0% |
| Q1 2022 | $6,897,000 | -23.5% | 373,394 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $9,014,000 | +3.0% | 379,241 | +6.8% | 0.00% | -50.0% |
| Q3 2021 | $8,749,000 | +30.5% | 355,230 | +31.0% | 0.00% | +100.0% |
| Q2 2021 | $6,704,000 | +6.9% | 271,270 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $6,274,000 | +27.9% | 287,679 | +49.7% | 0.00% | 0.0% |
| Q4 2020 | $4,905,000 | -9.9% | 192,223 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $5,445,000 | – | 193,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |